The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancer

被引:2
|
作者
Hines, Robert B. [1 ]
Schoborg, Christopher [2 ]
Sumner, Timothy [2 ]
Thiesfeldt, Dana-Leigh [3 ]
Zhang, Shunpu [2 ]
机构
[1] Univ Cent Florida, Coll Med, Dept Populat Hlth Sci, 900 Lake NonaBlvd, Orlando, FL 32827 USA
[2] Univ Cent Florida, Coll Sci, Dept Stat & Data Sci, Orlando, FL 32827 USA
[3] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32827 USA
关键词
colorectal cancer; chemotherapy-induced peripheral neuropathy; oxaliplatin; falls; QUALITY-OF-LIFE; RISK-FACTORS; ADJUVANT TREATMENT; CHEMOTHERAPY; HEALTH; INJURIES; CIRRHOSIS; FRAILTY; PEOPLE; CLAIMS;
D O I
10.1093/aje/kwae067
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our purpose was to investigate the associations between falls and oxaliplatin-induced peripheral neuropathy (OIPN), sociodemographic characteristics, and clinical characteristics of older patients with colorectal cancer. The study population consisted of older adults diagnosed with colorectal cancer whose data were obtained from the Surveillance, Epidemiology, and End Results database combined with Medicare claims. We defined OIPN using specific (OIPN 1) and broader (OIPN 2) definitions of OIPN, based on diagnosis codes. Extensions of the Cox regression model to accommodate repeated events were used to obtain overall hazard ratios (HRs) with 95% CIs and the cumulative hazard of fall. The unadjusted risk of fall for colorectal cancer survivors with versus without OIPN 1 at 36 months of follow-up was 19.6% versus 14.3%, respectively. The association of OIPN with time to fall was moderate (for OIPN 1, HR = 1.37; 95% CI, 1.04-1.79) to small (for OIPN 2, HR = 1.24; 95% CI, 1.01-1.53). Memantine, opioids, cannabinoids, prior history of fall, female sex, advanced age and disease stage, chronic liver disease, diabetes, and chronic obstructive pulmonary disease all increased the hazard rate of falling. Incorporating fall prevention in cancer care is essential to minimize morbidity and mortality of this serious event in older survivors of colorectal cancer.
引用
收藏
页码:1271 / 1280
页数:10
相关论文
共 50 条
  • [1] The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients
    Hines, Robert B.
    Schoborg, Christopher
    Sumner, Timothy
    Zhu, Xiang
    Elgin, Elizabeth A.
    Zhang, Shunpu
    SUPPORTIVE CARE IN CANCER, 2023, 31 (07)
  • [2] Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
    Griffith, Kathleen A.
    Zhu, Shijun
    Johantgen, Meg
    Kessler, Michael D.
    Renn, Cynthia
    Beutler, Andreas S.
    Kanwar, Rahul
    Ambulos, Nicholas
    Cavaletti, Guido
    Bruna, Jordi
    Briani, Chiara
    Argyriou, Andreas A.
    Kalofonos, Haralabos P.
    Yerges-Armstrong, Laura M.
    Dorsey, Susan G.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (05) : 701 - +
  • [3] The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients
    Robert B. Hines
    Christopher Schoborg
    Timothy Sumner
    Xiang Zhu
    Elizabeth A. Elgin
    Shunpu Zhang
    Supportive Care in Cancer, 2023, 31
  • [4] Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients
    Nagashima, Makoto
    Ooshiro, Mitsuru
    Moriyama, Ayako
    Sugishita, Yui
    Kadoya, Kengo
    Sato, Ayami
    Kitahara, Tomoaki
    Takagi, Ryuichi
    Urita, Tasuku
    Yoshida, Yutaka
    Tanaka, Hiroshi
    Oshiro, Takashi
    Okazumi, Shinichi
    Katoh, Ryoji
    SUPPORTIVE CARE IN CANCER, 2014, 22 (06) : 1579 - 1584
  • [5] Ultrasound Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Patients With Colorectal Cancer: A Pilot Study
    Chien, Andy
    Yang, Chen-Chia
    Chang, Sheng-Chi
    Jan, Yi-Min
    Yang, Ching-Hsiang
    Hsieh, Yueh-Ling
    PM&R, 2021, 13 (01) : 55 - 65
  • [6] Electroneurography in the evaluation of oxaliplatin-induced neuropathy in colorectal cancer patients
    Zygulska, A. L.
    Banach, M.
    Krzemieniecki, K.
    NEOPLASMA, 2016, 63 (04) : 617 - 622
  • [7] A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
    Sina Vatandoust
    Rohit Joshi
    Kenneth B. Pittman
    Adrian Esterman
    Vy Broadbridge
    Jacqueline Adams
    Nimit Singhal
    Susan Yeend
    Timothy Jay Price
    Supportive Care in Cancer, 2014, 22 : 513 - 518
  • [8] Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
    Mine, Keisuke
    Kawashiri, Takehiro
    Inoue, Mizuki
    Kobayashi, Daisuke
    Mori, Kohei
    Hiromoto, Shiori
    Kudamatsu, Hibiki
    Uchida, Mayako
    Egashira, Nobuaki
    Koyanagi, Satoru
    Ohdo, Shigehiro
    Shimazoe, Takao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [9] A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
    Vatandoust, Sina
    Joshi, Rohit
    Pittman, Kenneth B.
    Esterman, Adrian
    Broadbridge, Vy
    Adams, Jacqueline
    Singhal, Nimit
    Yeend, Susan
    Price, Timothy Jay
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 513 - 518
  • [10] Prospective Study of the Clinical, Electrophysiologic, and Sonographic Characteristics of Oxaliplatin-Induced Neuropathy
    Pitarokoili, Kalliopi
    Hoeffken, Nadine
    Loenneker, Niko
    Fisse, Anna Lena
    Trampe, Nadine
    Gold, Ralf
    Reinacher-Schick, Anke
    Yoon, Min-Suk
    JOURNAL OF NEUROIMAGING, 2019, 29 (01) : 133 - 139